3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Triple Negative Breast Neoplasms
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Gastrointestinal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Myelodysplastic Syndromes
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Histiocytoma, Malignant Fibrous
1
Hematologic Neoplasms
1
Giant Cell Tumor of Bone
1
Interventions
enzalutamide
21
Magnetic Resonance Spectroscopy
21
apalutamide
17
Androgen Antagonists
14
Specimen Handling
13
Prednisone
13
Abiraterone Acetate
13
abiraterone
9
Docetaxel
9
Radiotherapy
8
Biopsy
8
darolutamide
7
Radiosurgery
7
Pluvicto
7
Nivolumab
7
cabazitaxel
6
Lutetium-177
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
Lutetium
5
radium Ra 223 dichloride
4
pembrolizumab
4
niraparib
4
gallium 68 PSMA-11
4
cabozantinib
4
bicalutamide
4
atezolizumab
4
Watchful Waiting
4
Surveys and Questionnaires
4
Standard of Care
4
Radiotherapy, Intensity-Modulated
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
aldesleukin
×
30 days
×
Clear all
No trials found.